ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.073

+$0.003 (+4.29%)

Day Range

$0.071 - $0.074

52 Week Range

$0.065 - $0.125

Volume

1.55M

Avg Volume (10D)

668.60K

Market Cap

$88.24M

Price Chart

Market Statistics

Open$0.072

Previous Close$0.070

Day High$0.074

Day Low$0.071

52 Week High$0.125

52 Week Low$0.065

Valuation

Market Cap88.24M

Shares Outstanding1.21B

Price to Book4.44

Trading Activity

Volume1.55M

Value Traded112.40K

Bid$0.072 × 183,888

Ask$0.074 × 48,736

Performance

1 Day-1.41%

5 Day-6.67%

13 Week-22.22%

52 Week-2.78%

YTD-24.73%

Technical Indicators

RSI (14)46.69

50-Day SMA$0.075

200-Day SMA$0.084

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton